Brain amyloid and the transition to dementia in Down syndrome.

Alzheimer's & Dementia : Diagnosis, Assessment & Disease Monitoring
David B KeatorI T Lott

Abstract

Down syndrome (DS) is associated with elevated risk for Alzheimer's disease (AD) due to amyloid beta (Aβ) lifelong accumulation. We hypothesized that the spatial distribution of brain Aβ predicts future dementia conversion in individuals with DS. We acquired 18F-florbetapir positron emission tomography scans from 19 nondemented individuals with DS at baseline and monitored them for 4 years, with five individuals transitioning to dementia. Machine learning classification using an independent test set determined features on 18F-florbetapir standardized uptake value ratio maps that predicted transition. In addition to "AD signature" regions including the inferior parietal cortex, temporal lobes, and the cingulum, we found that Aβ cortical binding in the prefrontal and superior frontal cortices distinguished subjects who transitioned to dementia. Classification did well in predicting transitioners. Our study suggests that specific regional profiles of brain amyloid in older adults with DS may predict cognitive decline and are informative in evaluating the risk for dementia.

References

Jul 9, 2011·American Journal of Medical Genetics. Part a·Ira T LottDaniel L Gillen
Dec 24, 2011·Molecular Neurodegeneration·Yangling Mu, Fred H Gage
May 11, 2013·IEEE Transactions on Medical Imaging·Sune H KellerMerence Sibomana
Nov 5, 2014·International Journal of Geriatric Psychiatry·Rory SheehanAndre Strydom
Nov 10, 2015·BioMed Research International·Anna-Mariya KirovaSarita Lagalwar
Dec 19, 2016·Seminars in Nuclear Medicine·Atul MallikSatoshi Minoshima
Mar 16, 2017·Neuropsychology Review·Bianca Alexandra LautarescuShahid H Zaman
Apr 8, 2017·Neurobiology of Aging·Harry LeVineElizabeth Head
Jun 24, 2017·Alzheimer's & Dementia : Translational Research & Clinical Interventions·Dawn C MatthewsMichael S Rafii
Jul 18, 2017·Neurobiology of Aging·Sigan L HartleyBradley T Christian
Aug 2, 2017·Neurobiology of Aging·Sulantha MathotaarachchiUNKNOWN Alzheimer's Disease Neuroimaging Initiative
Aug 6, 2019·Developmental Neurobiology·Eric E AbrahamsonMilos D Ikonomovic

❮ Previous
Next ❯

Key Resources (RRID) Mentioned

SCR_001847
SCR_001905

Software Mentioned

R
FreeSurfer
PETSurfer

Related Concepts

Related Feeds

Alzheimer's Disease: Amyloid Beta

Alzheimer's disease is a neurodegenerative disease associated with the accumulation of amyloid plaques in the brain; these plaques are comprised of amyloid beta deposits. Here is the latest research in this field.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.